Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types

Fig. 3

Survival curves in lung adenocarcinoma patients harbouring EGFR mutations according to each mutation type. a, b Comparison of progression-free survival and overall survival for exon 19 deletion. c, d Comparison of progression-free survival and overall survival for L858R point mutation. e, f Comparison of progression-free survival and overall survival for uncommon mutations

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us